The initial public offer (IPO) of vaccine manufacturing firm GreenSignal Bio Pharma was subscribed 3 per cent on the first day of the offer today.
The Rs 112-crore IPO received bids for 3,95,500 shares against the total issue size of 1,45,79,560 shares, data available with NSE till 1746 hours showed.
The non-institutional investor portion was subscribed 1 per cent while the retail investor category was subscribed 26 per cent.
The company has entered the capital market with its IPO of 1,45,79,560 shares of face value of Rs 10 each through an offer for sale.
It has fixed the price band at Rs 76-80. The issue will close on November 11.
The shares are proposed to be listed on BSE and NSE.
The firm is into manufacturing of BCG vaccine given for protection against tuberculosis, mainly severe forms of child tuberculosis.
Disclaimer: No Business Standard Journalist was involved in creation of this content
